These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8632823)

  • 21. Stimulation of proteinase activated receptor-2 causes endothelial cells to promote blood coagulation in vitro.
    Alm AK; Norström E; Sundelin J; Nystedt S
    Thromb Haemost; 1999 Jun; 81(6):984-8. PubMed ID: 10404779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted disruption of the mouse Gz-alpha gene: a role for Gz in platelet function?
    Kelleher KL; Matthaei KI; Hendry IA
    Thromb Haemost; 2001 Mar; 85(3):529-32. PubMed ID: 11307826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombin receptor antagonists.
    Seiler SM
    Semin Thromb Hemost; 1996; 22(3):223-32. PubMed ID: 8836006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. G-protein-coupled receptors as signaling targets for antiplatelet therapy.
    Smyth SS; Woulfe DS; Weitz JI; Gachet C; Conley PB; Goodman SG; Roe MT; Kuliopulos A; Moliterno DJ; French PA; Steinhubl SR; Becker RC;
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):449-57. PubMed ID: 19023091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protease activated receptors 1 and 4 govern the responses of human platelets to thrombin.
    Ofosu FA
    Transfus Apher Sci; 2003 Jun; 28(3):265-8. PubMed ID: 12725953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates.
    Derian CK; Damiano BP; Addo MF; Darrow AL; D'Andrea MR; Nedelman M; Zhang HC; Maryanoff BE; Andrade-Gordon P
    J Pharmacol Exp Ther; 2003 Feb; 304(2):855-61. PubMed ID: 12538843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against thrombosis in mice lacking PAR3.
    Weiss EJ; Hamilton JR; Lease KE; Coughlin SR
    Blood; 2002 Nov; 100(9):3240-4. PubMed ID: 12384423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithrombotic strategies targeting thrombin activities, thrombin receptors and thrombin generation.
    Harker LA; Hanson SR; Kelly AB
    Thromb Haemost; 1997 Jul; 78(1):736-41. PubMed ID: 9198248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation.
    Covic L; Misra M; Badar J; Singh C; Kuliopulos A
    Nat Med; 2002 Oct; 8(10):1161-5. PubMed ID: 12357249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological consequences of thrombin receptor deficiency in mice.
    Darrow AL; Fung-Leung WP; Ye RD; Santulli RJ; Cheung WM; Derian CK; Burns CL; Damiano BP; Zhou L; Keenan CM; Peterson PA; Andrade-Gordon P
    Thromb Haemost; 1996 Dec; 76(6):860-6. PubMed ID: 8972001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mice lacking the thrombin receptor, PAR1, have normal skin wound healing.
    Connolly AJ; Suh DY; Hunt TK; Coughlin SR
    Am J Pathol; 1997 Nov; 151(5):1199-204. PubMed ID: 9358744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined deficiency of protease-activated receptor-4 and fibrinogen recapitulates the hemostatic defect but not the embryonic lethality of prothrombin deficiency.
    Camerer E; Duong DN; Hamilton JR; Coughlin SR
    Blood; 2004 Jan; 103(1):152-4. PubMed ID: 14504091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perinatal lethality of Par4
    French SL; Hamilton JR
    Platelets; 2018 Mar; 29(2):196-198. PubMed ID: 28960148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The thrombin receptor.
    Dennington PM; Berndt MC
    Clin Exp Pharmacol Physiol; 1994 May; 21(5):349-58. PubMed ID: 7955544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteolytically activated receptor-3. A member of an emerging gene family of protease receptors expressed on vascular endothelial cells and platelets.
    Cupit LD; Schmidt VA; Bahou WF
    Trends Cardiovasc Med; 1999; 9(1-2):42-8. PubMed ID: 10189966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibody to the thrombin receptor stimulates DNA synthesis in combination with gamma-thrombin or phorbol myristate acetate.
    Frost GH; Thompson WC; Carney DH
    J Cell Biol; 1987 Dec; 105(6 Pt 1):2551-8. PubMed ID: 2826490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice.
    Xue J; Wu Q; Westfield LA; Tuley EA; Lu D; Zhang Q; Shim K; Zheng X; Sadler JE
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7603-7. PubMed ID: 9636196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular effects of thrombin: pharmacology of the receptor(s) in various cell types and possible development of receptor antagonists.
    De Caterina R; Sicari R
    Pharmacol Res; 1993; 27(1):1-19. PubMed ID: 8384364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombin receptor function and cardiovascular disease.
    Coughlin SR
    Trends Cardiovasc Med; 1994; 4(2):77-83. PubMed ID: 21244899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.